IvyGene

Ivygene Diagnostics is a health care startup founded in 2017 with the slogan "Empowering early cancer detection through innovative and accessible biomedical technology." The company, a subsidiary of Laboratory for Advanced Medicine (LAM), is dedicated to revolutionizing cancer intervention and detection. Ivygene's flagship technology aims to transform cancer into a manageable and ultimately curable illness by enabling early detection. Emphasizing accessibility and affordability, LAM is committed to shifting cancer prevention and detection from reactive to proactive measures. Currently, there is no public information available about the company's headquarters, last investment, or associated investors.